MarketBeat provided an average rating and target price for Tenaya Therapeutics.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided an average rating and target price for Tenaya Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
Related events
- MarketBeat summarized current ratings and price targets for Arcturus Therapeutics.
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.
- MarketBeat provided average ratings and consensus price targets for Eagle Bancorp Montana.
- MarketBeat published average ratings and price targets for Kalaris Therapeutics, while Citigroup reaffirmed an outperform rating and TD Cowen initiated coverage with a buy rating.
- MarketBeat reported average ratings and consensus targets, while Desjardins provided a moderate buy rating for Stingray Digitl.